Personnel

Pharma company names member to scientific and technical advisory board

Published in Cancer Weekly, February 8th, 2005

Speedel announced that distinguished scientist Karl-Heinz Altmann, professor of pharmaceutical sciences at the Swiss Federal Institute of Technology (ETH) Zurich, has joined its scientific and technical advisory board.

Altmann was awarded a doctorate from the University of Basel in 1986 for his work in peptide chemistry and subsequently held posts at Cornell University, Ithaca, New York, USA and the University of Lausanne, Switzerland. From 1990-96 he worked at Ciba-Geigy Central Research Laboratories in Basel. He was a project leader in Oncology Research with Novartis Pharma AG from 1997-2000 during which period Altmann received the "Novartis Leading Scientist...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2005-02-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry